Finanzen von Creative Medical Technology Holdings Inc (CELZ)CELZCreative Medical Technology Holdings Inc

Evaluating the bottom line, Creative Medical Technology Holdings Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -78.03%, provide a clear picture of how effectively CELZ converts its operational activities into shareholder value.

In the context of the broader market, CELZ competes directly with industry leaders such as WOK and TRIB. With a market capitalization of $4.71M, it holds a significant position in the sector. When comparing efficiency, CELZ's gross margin of N/A stands against WOK's 19.14% and TRIB's 35.43%. Such benchmarking helps identify whether Creative Medical Technology Holdings Inc is trading at a premium or discount relative to its financial performance.

Creative Medical has shown inconsistent revenue, with total revenue of $3,000 in Q4 2024 and losses in subsequent quarters. The gross margin remains negative, indicating challenges in cost management.